Compare SHEN & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHEN | TLRY |
|---|---|---|
| Founded | 1902 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 803.5M | 919.2M |
| IPO Year | 1994 | 2018 |
| Metric | SHEN | TLRY |
|---|---|---|
| Price | $14.61 | $6.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $26.00 | ★ $103.33 |
| AVG Volume (30 Days) | 222.2K | ★ 2.2M |
| Earning Date | 04-29-2026 | 04-07-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $357,854,000.00 | N/A |
| Revenue This Year | $6.58 | $7.39 |
| Revenue Next Year | N/A | $4.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.08 | N/A |
| 52 Week Low | $9.67 | $0.36 |
| 52 Week High | $15.92 | $15.70 |
| Indicator | SHEN | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 59.24 | 34.92 |
| Support Level | $14.31 | $1.00 |
| Resistance Level | $15.86 | $8.20 |
| Average True Range (ATR) | 0.64 | 0.32 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 47.01 | 0.16 |
Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.